Skip to main content
CAMP $5.44 +20.89%
CAMP logo

CAMP · Camp4 Therapeutics Corp

Track CAMP — free
$5.44 +0.94 (+20.89%) At close · Aug 14
Market Cap
$341.38M
Shares
62.75M
All earnings calls

Earnings call · FY2024 Q3

Camp4 Therapeutics Corp Q3 FY2024 Earnings Call

Camp4 Therapeutics Corp Q3 FY2024 Earnings Call

Concluded Nov 21, 2024
Nov 21, 2024 16 turns
Period
FY2024 Q3
Runtime
Sources
3 artifacts

Executive readout · one minute

Call research workspace

Read the call alongside every captured source. Audio, transcript, slides and SEC filings stay in one workspace.

TSP demand and recovery 22 Lynrock financing and capital structure 12 Vision 2.1 and product launches 11 Cost reduction and operating model 9 DMCTC migration completion 8 International connected car wins 8

Management tone

Balanced

Net tone +5 · moderate hedging

Grounding quotes
  • “In the third quarter, CalAmp continued to see strength in certain areas of the business, while also experiencing demand softness in others.”
  • “We are optimistic that TSP revenue will stabilize and return to growth from current levels.”
  • “Overall, the company generated $53.6 million in revenue and $1 million of adjusted EBITDA in the quarter, both of which fell below our expectations”
  • “Being realistic, I think that recovery is going to be slow. It's going to take us a while to get back up to historical levels, but like I said, we're optimistic.”

Research coverage

3 live sources

Switch sources without leaving this page or losing your listening position.

Revenue $0 -100% YoY
Diluted EPS -$24.19
Net income -$13.48M

Research materials

Open the source you need; every reader stays inside this workspace.

Full-screen source Call document